140 related articles for article (PubMed ID: 24286084)
21. Co-production of SFO-1 and DHA-1 β-lactamases and 16S rRNA methylase ArmA in clinical isolates of Klebsiella pneumoniae.
Guo Q; Wang P; Ma Y; Yang Y; Ye X; Wang M
J Antimicrob Chemother; 2012 Oct; 67(10):2361-6. PubMed ID: 22778158
[TBL] [Abstract][Full Text] [Related]
22. Detection of a CTX-M group 2 beta-lactamase gene in a Klebsiella pneumoniae isolate from a tertiary care hospital, Trinidad and Tobago.
Cheddie P; Dziva F; Akpaka PE
Ann Clin Microbiol Antimicrob; 2017 May; 16(1):33. PubMed ID: 28482925
[TBL] [Abstract][Full Text] [Related]
23. Dissemination of the
Tian D; Wang B; Zhang H; Pan F; Wang C; Shi Y; Sun Y
mSphere; 2020 Jan; 5(1):. PubMed ID: 31915216
[TBL] [Abstract][Full Text] [Related]
24. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
Rzeczkowska M; Piekarska K; Gierczyński R
Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria).
Messai Y; Iabadene H; Benhassine T; Alouache S; Tazir M; Gautier V; Arlet G; Bakour R
Pathol Biol (Paris); 2008 Jul; 56(5):319-25. PubMed ID: 18585867
[TBL] [Abstract][Full Text] [Related]
26. Detection of OXA-1 β-lactamase gene of Klebsiella pneumoniae from blood stream infections (BSI) by conventional PCR and in-silico analysis to understand the mechanism of OXA mediated resistance.
Sugumar M; Kumar KM; Manoharan A; Anbarasu A; Ramaiah S
PLoS One; 2014; 9(3):e91800. PubMed ID: 24647004
[TBL] [Abstract][Full Text] [Related]
27. [Characterization and molecular epidemiology of ESBL in Escherichia coli and Klebsiella pneumoniae in 11 Spanish hospitals (2004)].
Diestra K; Coque TM; Miró E; Oteo J; Nicolau CJ; Campos J; Moyá B; Curiao T; Pérez-Vázquez M; Cantón R; Oliver A; Navarro F;
Enferm Infecc Microbiol Clin; 2008; 26(7):404-10. PubMed ID: 18842234
[TBL] [Abstract][Full Text] [Related]
28. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
[TBL] [Abstract][Full Text] [Related]
29. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
[TBL] [Abstract][Full Text] [Related]
30. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey.
Aktaş Z; Kayacan CB; Schneider I; Can B; Midilli K; Bauernfeind A
Chemotherapy; 2008; 54(2):101-6. PubMed ID: 18303258
[TBL] [Abstract][Full Text] [Related]
31. Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein.
Dahmen S; Mansour W; Charfi K; Boujaafar N; Arlet G; Bouallègue O
Microb Drug Resist; 2012 Oct; 18(5):479-83. PubMed ID: 22690752
[TBL] [Abstract][Full Text] [Related]
32. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
[TBL] [Abstract][Full Text] [Related]
33. Dominance of blaCTX-M within an Australian extended-spectrum beta-lactamase gene pool.
Zong Z; Partridge SR; Thomas L; Iredell JR
Antimicrob Agents Chemother; 2008 Nov; 52(11):4198-202. PubMed ID: 18725449
[TBL] [Abstract][Full Text] [Related]
34. Distribution of
Abrar S; Ain NU; Liaqat H; Hussain S; Rasheed F; Riaz S
Antimicrob Resist Infect Control; 2019; 8():80. PubMed ID: 31139363
[TBL] [Abstract][Full Text] [Related]
35. "Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio.
Viau RA; Hujer AM; Marshall SH; Perez F; Hujer KM; Briceño DF; Dul M; Jacobs MR; Grossberg R; Toltzis P; Bonomo RA
Clin Infect Dis; 2012 May; 54(9):1314-21. PubMed ID: 22492318
[TBL] [Abstract][Full Text] [Related]
36. Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey.
Nazik H; Ongen B; Ilktac M; Aydin S; Kuvat N; Sahin A; Yemisen M; Mete B; Durmus MS; Balkan II; Yildiz I; Ergul Y
Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1178-85. PubMed ID: 23431824
[TBL] [Abstract][Full Text] [Related]
37. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit.
Bagattini M; Crivaro V; Di Popolo A; Gentile F; Scarcella A; Triassi M; Villari P; Zarrilli R
J Antimicrob Chemother; 2006 May; 57(5):979-82. PubMed ID: 16531430
[TBL] [Abstract][Full Text] [Related]
38. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
Mendonça N; Ferreira E; Louro D; ; Caniça M
Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
[TBL] [Abstract][Full Text] [Related]
39. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
Peirano G; Seki LM; Val Passos VL; Pinto MC; Guerra LR; Asensi MD
J Antimicrob Chemother; 2009 Feb; 63(2):265-8. PubMed ID: 19028717
[TBL] [Abstract][Full Text] [Related]
40. Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study.
Shakil S; Khan AU
Ann Clin Microbiol Antimicrob; 2010 Jan; 9():2. PubMed ID: 20070911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
